web analytics

Daily Review 06/10/2015

Written By: - Date published: 6:00 pm, October 6th, 2015 - 34 comments
Categories: Daily review - Tags:

natives discovered columbus

Daily review is also your post.

This provides Standardistas the opportunity to review events of the day.

The usual rules of good behaviour apply (see the Policy).

Don’t forget to be kind to each other.

34 comments on “Daily Review 06/10/2015 ”

  1. NZJester 1

    Small class sizes a key factor in charter school success – report
    5:50 PM Tuesday Oct 6, 2015

    Smaller class sizes because of better funding leads to better education results for student?
    My god how dare those terrible public schools increase their class sizes and under fund themselves then.

    Oh sorry my mistake it was the government that did that not the schools!

    How much better do you think the results would have been for a public school if it got the same amount of money per student as money given to an average charter school considering that large portions of that money would not need to go as profit in to the schools owners pockets?

  2. joe90 2

    Rust never sleeps.

    The TPP Will Finish What Chile’s Dictatorship Started

    Salvador Allende warned against neoliberalism’s disastrous effects just before he was overthrown. He was right to be worried.


    But Allende offered a pretty good definition back in 1972, in a speech to the United Nations given less than a year before his overthrow and death. He said: “We are faced by a direct confrontation between the large transnational corporations and the states. The corporations are interfering in the fundamental political, economic and military decisions of the states. The corporations are global organizations that do not depend on any state and whose activities are not controlled by, nor are they accountable to any parliament or any other institution representative of the collective interest. In short, all the world political structure is being undermined.”


    • joe90 2.1

      Talley’s come to mind.

      19. Labour

      All TPP Parties are International Labour Organization (ILO) members and recognize the importance of promoting internationally recognized labour rights. TPP Parties agree to adopt and maintain in their laws and practices the fundamental labour rights as recognized in the ILO 1998 Declaration, namely freedom of association and the right to collective bargaining; elimination of forced labour; abolition of child labour and a prohibition on the worst forms of child labour; and elimination of discrimination in employment.


    • Bill 2.2

      It’s a protection racket is all.

      I [insert corporation and activity of choice] insist on investing in or carrying out activity x, y or z.

      If you [democratically elected governing body] want to prevent me, then you can come along to this international ‘back-room’ court here, where ‘the boys’ and me – we’ll sit down and decide the compensation/protection money due.

      It never was a trade deal.

      As an ‘aside’, the 5 or 7 year (or whatever) limitation that Australia wrested on patents…perhaps not what I thought it was. (surprise, surprise)

      According to ‘Doctors Without Borders’ (Médecins Sans Frontières)…

      …the TPP would lower the standard for patentability of medicines. It would force TPP governments to grant pharmaceutical companies additional patents for changes to existing medicines, even when the changes provide no therapeutic benefit to patients. These provisions would facilitate “evergreening” …

      … the TPP involves so-called “data exclusivity” for biologics,…Data exclusivity blocks competing firms from using previously generated clinical trial data to gain approval for generic versions of these drugs and vaccines.


      • vto 2.2.1

        What about the people that will die because of that?

      • northshoredoc 2.2.2

        For the umpteenth time…..

        Data exclusivity in relation to pharmaceuticals is all about generics ability to rely on the clinical and hefty data or an originator to register their medication with a regulatory body such as Medsafe in NZ or the FDA in the USA.

        This data exclusivity period, 5 years in NZ at present, is almost always far shorter than the patent life of the pharmaceutical in question except in the case of of medicine which has never sought a patent in the country in question.

        • joe90

          Stiglitz seems to be saying they’ll quietly tilt the paddock to suit.

          The TPP would manage trade in pharmaceuticals through a variety of seemingly arcane rule changes on issues such as “patent linkage,” “data exclusivity,” and “biologics.” The upshot is that pharmaceutical companies would effectively be allowed to extend – sometimes almost indefinitely – their monopolies on patented medicines, keep cheaper generics off the market, and block “biosimilar” competitors from introducing new medicines for years. That is how the TPP will manage trade for the pharmaceutical industry if the US gets its way.


          • vto

            But what about the people that will die because of that?

            Surely the most appropriate structure is the reverse of that i.e. nothing can be patented so that all of human ingenuity is able to be instantly fed back into all of human ingenuity.

            Putting in place a structure to make medicine expensive just doesn’t make sense in a sector that is about saving lives.

            Unless it is not about saving lives

            • northshoredoc

              “Surely the most appropriate structure is the reverse of that i.e. nothing can be patented so that all of human ingenuity is able to be instantly fed back into all of human ingenuity.”

              Well probably the best example of that would be India which among countries which produce pharmaceuticals has the most relaxed patent laws – not surprisingly they produce few to no new pharmaceuticals compounds compared to those countries where there is stronger patent protections.

              • vto

                That doesn’t follow though doc….

                It might on the face of it be a convenient reason that jumps out after little consideration….

                But nope it doesn’t follow. Unless the cart pushed the horse, for example,,,

                • northshoredoc

                  It may not follow for you but it must for those producing the medications and other products as there’s many a trademark and patent that has been issued over the last hundred years to those applying for them must see value in them to both protect their invention and produce income.

                  • vto

                    Yes doc, but my point was around the people that will die because of medical patents, not around income for inventors of medical patents.

                    For your point (that patents, and the associated money, lead to more medical advances) to be tested, all patents would need to be canned to see whether the rate of medical advance slows across humanity. By having a mix between, say, the US with massive patent protection and India with little patent protection, it is not possible to assess whether patents work in the way you think, because India will simply copy. Wont it.

                    Here is another one for you – which country saves the most lives (to put it crudely) with their medicines? The US with its expensive ones? Or India with its cheap copies? It is a simple numbers question – do you know?

                    • northshoredoc

                      VTO the medicines available and produced in India are with only a very very small exception all inventions from outside of India.

                      I do not know the answer to your question which is somewhat meaningless however i can tell you that in both countries the access to quality healthcare is somewhat dependent on your income and sadly this is probably less so the case in the USA than India.

                      Unlike both those countries we have a quality public health system available to all.

                    • vto

                      I wouldn’t have thought a question to find out how many unnecessary deaths result from expensive medicines due to patents is meaningless at all…

                      Another way your favoured patents work against the complete bulk of humanity is that the advances that are discovered by patent-keepers will mostly only ever get to the rich. So yep, the rich keep getting new medical advances prolonging healthier lives, but the rest of humanity get nothing, zip, nada, ever. It always is only the rich that benefit from medical patents…

                      …perhaps no surprise that it is the world’s richest country that promotes medical patents so ferociously

                    • northshoredoc


                      “Another way your favoured patents work against the complete bulk of humanity is that the advances that are discovered by patent-keepers will mostly only ever get to the rich. So yep, the rich keep getting new medical advances prolonging healthier lives, but the rest of humanity get nothing, zip, nada, ever. It always is only the rich that benefit from medical patents…”

                      ..and yet we have the patent system in place in most countries around the world and taking NZ as an example where we have a 20 year patent term from the discovery of the new molecule most of our medicines are from generic suppliers.. has the penny dropped ?

                    • vto

                      ships in the night mate

        • miravox

          I don’t know about you northshoredoc, even if the TPPA is business as usual for Pharmac, I was hoping to have better access to biologics in this deal. After all, it is a deal that is supposed to be about improving access to goods and services as well as selling stuff.

          I am aware that since I left NZ a few years ago biologics have become more available but due to cost there are still not enough of them and the criteria that has to be met is literally crippling for some people. Believe me, I know.

          I also know that when a biologic I’m on invariably stops doing the job I can easily get another biologic that works again, rather adding various combinations of DMARDs. I doubt that NZ-based patients have similar access. I also doubt that these combinations of drugs meet international best practice.

          Apart from the non-existent improvement in access to biologics in the TPPA the extra administrative costs also worry me. If the costs have to be absorbed by Pharmac and the cost to patients not increased, the only option I see is making the criteria for access even more onerous. Otherwise some other health sector will have funding curtailed. It may only be a ‘rounding error’ but a few million still needs to be found somewhere.

          I also get the impression that the 5 years is of data exclusivity is not set in stone. I guess in 90 days we’ll find out.

          Anyway, off for my morning jog (another half marathon coming up in the Spring) – sure beats losing my job because I couldn’t hold a pen and having to sell my home because I couldn’t walk up the hill to it – would be good if I knew I could come home and do the same because biologics would become cheaper and more accessible due to freeing up of patents in the TPPA.

          • northshoredoc

            I certainly sympathise with you in relation to your RA.

            NZ has three biologics currently available for RA under authority criteria which I believe is broadly similar to the access criteria in Aus and the UK, Etanercept, Adalimumab and Infliximab.

            PHARMAC have chosen not to list the newer agents such as ustekinumab at this team due to the pricing, as I’m pretty certain these medicines will have a long patent in the country where your currently accessing them and NZ I’m not sure how the TPPA would have been expected to effect their availability in NZ which is primarily down to PHARMAC looking at their cost vs the three we currently have available.

            • miravox

              Thanks for your reply

              So NZ access hasn’t changed much since I’ve been away, with 3 biologics and the same clinical criteria to meet (according to the Pharmac website). Aus has 8 biologics and criteria that is based on worsening disease. NZ has detailed clinical criteria that must be met or worked around. The differences, imo, are quite large. UK has a access more in-line with Australia than NZ.

              “…down to PHARMAC looking at their cost vs the three we currently have available.”

              Yes. And a ‘free trade’ agreement should be able to bring about lower costs. This has not and will not happen with the TPP. Instead people are arguing about whether the current inadequate access will remain, and are ‘relaxed’ that this may have been secured. It seems too much to actually want a deal that might improve access to a level that meets, say, the ACR/EULAR recommendations for implementing biologics. Business as usual is not a great result imo.

              Moreover, the extra costs on Pharmac as a result of the TPP agreement are passed off as mere irritants. I’ll be watching with interest to see what the government plan for meeting these costs is. If it is a tightening of criteria, that will be disastrous for some people and frustrating for specialists who already working within too tight criteria.

              I’m sure you agree that the cost of biologics and other similar meds are so high that it’s incredibly important to lower them, not only for the patients who might benefit directly, but also to ensure the costs don’t put pressure on other areas of the health budget (not to mention a reduction in the need for benefits due to illness).

              • northshoredoc

                A few things, a free trade agreement is not likely to bring about a lowering of costs for these products before there are very cheap generics of these compounds actually available.

                The cheapest of these in NZ is now infliximab which is now around $NZ350 per infusion after rebate – the cheapest price in the world I believe significantly lower even than those countries where there is generic competition. The barrier to entry for the extra 5 that are available in Aus will be that if they have been assessed by PHARMAC they will have had little to no superiority to the products currently available and will be significantly more expensive – as I’m sure you know that’s the way PHARMAC works.

                The extra costs to PHARMAC under the TPP are a nothing. Your comment regarding business was usual for access to biologics has more to do with PHARMACs operating policies and procedures and the way they manage their budget than any trade agreement and will continue to do so.

                • miravox

                  “a free trade agreement is not likely to bring about a lowering of costs for these products before there are very cheap generics of these compounds actually available.”

                  This is a bit of a chicken and egg argument I think. Imo, a free trade agreement could bring about cheaper generics, but the TPP is not that.

                  I do understand, and appreciate, how PHARMAC can negotiate for cheaper prices. I won’t go into the ins and outs ‘no superiority’ decisions, except to say the biologic I’m on (not available in NZ) is because another (available in NZ) produced unacceptable side effects. Therefore I’d happier if there is a greater range available in NZ.

                  “PHARMACs operating policies and procedures” are developed in the context of price and availability. Two things freeing up of trade should address, I would have thought. I agree the TPP is not a vehicle for that in terms of pharmaceuticals.

                  • northshoredoc

                    “This is a bit of a chicken and egg argument I think. Imo, a free trade agreement could bring about cheaper generics, but the TPP is not that.”

                    I’m not sure how you think that would work, unless you are advocating a removal of patents for medicines in NZ – and even then none of the currently available biologics for RA have generic versions available excepting infliximab and as I mentioned the originator infliximab in NZ is funded at a lower price than the generic is anywhere in the world.

                    The other biologics are likely to be registered in NZ just not funded by PHARMAC, the TPP will have no effect on the ability of anyone to register their medicines here in relation to pricing again the TPP does not stop any supplier negotiating with PHARMAC for funding the supply of their medicine – the biggest hurdle will be for them to try to supply their medicine at a price acceptable to PHARMAC.

                    • miravox

                      “I’m not sure how you think that would work”

                      I don’t have an opinion on how it would/wouldn’t work, but I understand the question of whether patents improve innovation and supply is currently being questioned. The patent question is however, what the biologic protection in the TPP is all about.

                      And now I’m back to where I started – I don’t think a positive spin on retaining the same, or slightly lower, inadequate access to biologics in a ‘free trade’ agreement is justified. It’s depressing that Pharmac must work within the parameters it does. These drugs are life-changing not just some nice to have alternative to DMARDs. At least the Pharmac model can be seen to improve competitive pricing between suppliers, I suppose, unlike the TPP.

                      Again, I’ll be very interested to see how the ’rounding error’ in terms of increased costs will play out, given that the benefits of the deal come after the costs are incurred. This is curiosity, not judgement statement. For obvious reasons I do (hopefully unnecessarily) worry that access to biologics might be tightened more than it is now through tweaking clinical criteria that is already set too high, imo. It may not be much money in terms of the health system, but is something to think about if Pharmac funding is not increased to cover these extra TPP costs.

                      I’m certainly not disagreeing with what you say about patents, I just think maintaining the status quo at best is not something to cheer about. As for registered, but unfunded drugs… best not go there in terms of whether some people might gain access to them and not others, and what that means for equitable treatment in a public health system. I see a slippery slope argument coming on… 😉

          • Ad

            That is a really tough and highly personal story to share Miravox – great courage shown there, and a cold dose of reality to the trade theories ricocheting around.

            Good on you.

            • miravox

              Thanks Ad

              I guess not many people understand what these drugs can to for people who have chronic autoimmune diseases (or even what diseases mean).

              What drives me is that I’m incredibly lucky in how my treatment path has gone. I know people out there who have terrible disease with poor outcomes in all areas of their lives because their disease is not under control. The pressures on them and their families is immense.

              And yes, well noted – this is not just an theoretical argument for them. We tend to lose sight of that sometimes.

  3. vto 3

    Great photo at top of Daily Review..

    Reminds me of the person who, on the 200th anniversary of the English annexation of Australia, stuck an aboriginal flag in English soil and claimed it for the aboriginal nation.

    There but for the number of guns eh ….

    The only determinative….

    The number of guns …..


    • Bearded Git 3.1

      I was there for that 200th anniversary in Oz-there were a group of aborigines walking down George Street with a big sign saying ‘if you feel like this after 200 years imagine how you would feel after 40,000″.

  4. Just been listening to John Campbell out at Wairoa talking to the Affco workers. Great stuff, well worth a listen:


  5. Draco T Bastard 5

    How Coca-Cola tricked you into drinking so much of it

    You may think you have come to like soft drinks all on your own. But that desire is the product of decades worth of focused and often troubling efforts on behalf of the soft drink industry.

    This is, in so many words, one of the takeaways from a new book about how the industry has paid, lobbied and hypnotised its way into the hearts of people around the world. The book, called “Soda Politics,” is written by esteemed New York University professor and long-time food industry activist Marion Nestle. And it will leave a sour taste in anyone’s mouth.

    As I say, Advertising is psychopathic and needs to be banned.

  6. Draco T Bastard 6

    and this one:

    Still, what this amounts to is a non-trivial penalty for a company using dark UX patterns to trick users into doing things they don’t really want to do. As Dark Patterns, an excellent resource on these kinds of tactics, explains, this sort of bad design is purposeful. “They are not mistakes, they are carefully crafted with a solid understanding of human psychology, and they do not have the user’s interests in mind.”

    As social networks and other online products increasingly try to grow their users bases, it’s important to hold them accountable for their bad design, especially when that bad design is on purpose. Hopefully, this will serve as a warning to other companies who use shady tactics and dark UX patterns to artificially grow their products.

    Hell, we may as well admit it – the state of capitalist business itself is psychopathic.

  7. Ad 7

    What to do when the news is good and getting better?

    1.9b globally in poverty in 1990

    702m globally in poverty in 2015

    (based on the $1.90 ppp poverty line)


    On the back of this data, the World Bank believes eradicating world poverty is possible.

Recent Comments

Recent Posts

  • NZ announces a third P-3 deployment in support of UN sanctions
    The Government has deployed a Royal New Zealand Air Force P-3K2 Orion (P-3) maritime patrol aircraft to support the implementation of United Nations Security Council (UNSC) resolutions imposing sanctions against North Korea, announced Minister of Foreign Affairs Winston Peters and Minister of Defence Ron Mark. “New Zealand has long supported ...
    BeehiveBy beehive.govt.nz
    3 days ago
  • Pacific trade and development agreement a reality
    Pacific regional trade and development agreement PACER Plus will enter into force in 60 days now that the required eight countries have ratified it. Trade and Export Growth Minister David Parker welcomed the announcement that the Cook Islands is the eighth nation to ratify this landmark agreement. “The agreement represents ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • Securing a pipeline of teachers
    The Government is changing its approach to teacher recruitment as COVID-19 travel restrictions continue, by boosting a range of initiatives to get more Kiwis into teaching. “When we came into Government, we were faced with a teacher supply crisis,” Education Minister Chris Hipkins said. “Over the past three years, we ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • Border exceptions for a small number of international students with visas
    The Government has established a new category that will allow 250 international PhD and postgraduate students to enter New Zealand and continue their studies, in the latest set of border exceptions. “The health, safety and wellbeing of people in New Zealand remains the Government’s top priority. Tight border restrictions remain ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • First COVID-19 vaccine purchase agreement signed
    The Government has signed an agreement to purchase 1.5 million COVID-19 vaccines – enough for 750,000 people – from Pfizer and BioNTech, subject to the vaccine successfully completing all clinical trials and passing regulatory approvals in New Zealand, say Research, Science and Innovation Minister Megan Woods and Health Minister Chris Hipkins. ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • International statement – End-to-end encryption and public safety
    We, the undersigned, support strong encryption, which plays a crucial role in protecting personal data, privacy, intellectual property, trade secrets and cyber security.  It also serves a vital purpose in repressive states to protect journalists, human rights defenders and other vulnerable people, as stated in the 2017 resolution of the ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • Ministry of Defence Biodefence Assessment released
    The Ministry of Defence has today released a Defence Assessment examining Defence’s role across the spectrum of biological hazards and threats facing New Zealand. Biodefence: Preparing for a New Era of Biological Hazards and Threats looks at how the NZDF supports other agencies’ biodefence activities, and considers the context of ...
    BeehiveBy beehive.govt.nz
    1 week ago
  • New Approaches to Economic Challenges: Confronting Planetary Emergencies: OECD 9 October 2020
    New Approaches to Economic Challenges: Confronting Planetary Emergencies: OECD 9 October 2020 Hon David Parker’s response following Thomas Piketty and Esther Duflo. Good morning, good afternoon, and good evening, wherever in the world you might be. I first acknowledge the excellent thought provoking speeches of Thomas Piketty and Esther ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Kaipara Moana restoration takes next step
    A Memorandum of Understanding has been signed today at Waihāua Marae between the Crown, local iwi and councils to protect, restore and enhance the mauri of Kaipara Moana in Northland. Environment Minister David Parker signed the document on behalf of the Crown along with representatives from Ngā Maunga Whakahī, Ngāti ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • New Zealand and Uruguay unite on reducing livestock production emissions
    Agriculture Minister Damien O’Connor and Uruguayan Minister of Livestock, Agriculture and Fisheries Carlos María Uriarte have welcomed the launch of a three-year project that will underpin sustainable livestock production in Uruguay, Argentina, and Costa Rica.  The project called ‘Innovation for pasture management’ is led by Uruguay’s National Institute of Agricultural ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • 3100 jobs created through marae upgrades
    Hundreds of marae throughout the country will be upgraded through investments from the Provincial Growth Fund’s refocused post COVID-19 funding to create jobs and put money into the pockets of local tradespeople and businesses, Regional Economic Development Minister Shane Jones and Māori Development Minister Nanaia Mahuta have announced. “A total ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Health volunteers recognised in annual awards
    Health Minister Chris Hipkins has announced 9 teams and 14 individuals are the recipients of this year’s Minister of Health Volunteer Awards.  “The health volunteer awards celebrate and recognise the thousands of dedicated health sector volunteers who give many hours of their time to help other New Zealanders,” Mr Hipkins ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Community COVID-19 Fund supports Pacific recovery
    The Minister for Pacific Peoples, Aupito William Sio says a total of 264 groups and individuals have successfully applied for the Pacific Aotearoa Community COVID-19 Recovery Fund, that will support Pacific communities drive their own COVID-19 recovery strategies, initiatives, and actions. “I am keen to see this Fund support Pacific ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Community benefits from Māori apprenticeships
    Up to 50 Māori apprentices in Wellington will receive paid training to build houses for their local communities, thanks to a $2.75 million investment from the Māori Trades and Training Fund, announced Employment Minister Willie Jackson today. “This funding will enable Ngāti Toa Rangatira Incorporated to provide its Ngā Kaimahi ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Training fund supports Māori jobseekers
    Rapidly growing sectors will benefit from a $990,000 Māori Trades and Training Fund investment which will see Wellington jobseekers supported into work, announced Employment Minister Willie Jackson today. “This funding will enable Sapphire Consultants Ltd. to help up to 45 Māori jobseekers into paid training initiatives over two years through ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Ruakura Inland Port development vital infrastructure for Waikato
    The Government is investing $40 million to develop an inland port at Ruakura which will become a freight super-hub and a future business, research and residential development for the Waikato, Urban Development and Transport Minister Phil Twyford, and Māori Development Minister Nanaia Mahuta announced today. The funding has been has ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Appointments made to Defence Expert Review Group
    Defence Minister Ron Mark announced today the establishment of an Expert Review Group to review a number of aspects of the New Zealand Defence Force’s (NZDF) structure, information management and record-keeping processes.  The Expert Review Group’s work arises out of the first recommendation from the Report of the Government’s Inquiry ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • No active community cases of COVID-19
    There are no active community cases of COVID-19 remaining in the country after the last people from the recent outbreak have recovered from the virus, Health Minister Chris Hipkins said today. “This is a big milestone. New Zealanders have once again through their collective actions squashed the virus. The systems ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Clean energy upgrade for more public buildings
    More public buildings will be supported by the Government to upgrade to run on clean energy, the Minister for Climate Change James Shaw announced today. Minister Shaw announced that Lincoln and Auckland universities will receive support through the Clean-Powered Public Service Fund to replace fossil fuel boilers. Southern, Taranaki, and ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Schools back donations scheme for the second year
    More schools have opted in to the donations scheme for 2021, compared to 2020 when the scheme was introduced. “The families of more than 447,000 students will be better off next year, with 94% of eligible schools and kura opting into the scheme,” Education Minister Chris Hipkins said. “This is ...
    BeehiveBy beehive.govt.nz
    2 weeks ago
  • Ruapehu cycle trails gets PGF boost
    The spectacular Mountains to Sea cycle trail in Ruapehu District will receive $4.6 million in funding from the Provincial Growth Fund for two additional trails, Regional Economic Development Minister Shane Jones announced today. “This is an exciting development for the local community, and one that will provide significant economic opportunities ...
    BeehiveBy beehive.govt.nz
    3 weeks ago